Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 6/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | NPY4R | P50391 | 1/20 | 0.50 |
| ▸ | REN | P00797 | 2/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.45 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.45 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29798007 | 0.97 | OPRK1 (0.55) | OPRK1NPY1RNPY2RNPY4RREN | |
| SCHEMBL9747710 | 0.94 | ERAP2 (0.47) | OPRK1ERAP2LNPEP | |
| SCHEMBL29531327 | 0.94 | ERAP2 (0.47) | OPRK1ERAP2LNPEP | |
| SCHEMBL9747696 | 0.94 | ERAP2 (0.47) | OPRK1ERAP2LNPEP | |
| SCHEMBL29798193 | 0.94 | OPRK1 (0.52) | OPRK1NPY1RNPY2RNPY4RKISS1R | |
| SCHEMBL30645273 | 0.92 | NPY4R (0.47) | OPRK1NPY1RNPY2RNPY4RREN | |
| SCHEMBL30645270 | 0.92 | NPY4R (0.47) | OPRK1NPY1RNPY2RNPY4RREN | |
| SCHEMBL29531754 | 0.92 | MME (0.50) | — | |
| SCHEMBL30728889 | 0.92 | MME (0.50) | — | |
| SCHEMBL29531670 | 0.91 | OPRK1 (0.44) | OPRK1NPY1RNPY2RNPY4RREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220259265-A1 | Inhibitors and Use Thereof in Cancer Treatment | THE UNIVERSITY OF SYDNEY (AU) | 2022-08-18 | — | — | US | disclosed |